Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Crowley

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Advances in Therapy|June 18, 2026
Correction: Transition Care for Young People with Rare Bone and Mineral Conditions: A Scoping ReviewSílvia Coutinho, Lise Sofie Jensen, Thilini H Gamage, et al.
Calcified Tissue International|August 4, 2022
Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 StudyMaria Luisa Brandi, Suzanne Jan de Beur, Karine Briot, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2024
Systematic Review: Efficacy of Medical Therapy on Outcomes Important to Adult Patients With X-Linked HypophosphatemiaDalal S Ali, Reza D Mirza, Farah Alsarraf, et al.
RMD Open|September 22, 2021
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extensionKarine Briot, Anthony A Portale, Maria Luisa Brandi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 2025
Current Practices in Monitoring Children and Adults with X-linked Hypophosphatemia: A Global Survey of Expert ExperienceDalal S Ali, Farah Alsarraf, Hajar Abu Alrob, et al.
Journal of Bone and Mineral Metabolism|March 22, 2025
Methodology for the international working group clinical practice guidelines on X-linked hypophosphatemia in children and adultsDalal S Ali, Aliya A Khan, Reza D Mirza, et al.
Annals of the Rheumatic Diseases|December 20, 2023
Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget's disease of boneJonathan Phillips, Deepak Subedi, Steff C Lewis, et al.
ERJ Open Research|January 21, 2026
Clinical characteristics of diffuse idiopathic pulmonary neuroendocrine cell hyperplasiaMarissa O'Callaghan, Sarah H Forde, Alessandro N Franciosi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 17, 2020
Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study CohortOwen Cronin, Deepak Subedi, Laura Forsyth, et al.
Calcified Tissue International|November 8, 2025
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis ImperfectaJannie Dahl Hald, Christopher Weir, Catriona Keerie, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Advances in Therapy|June 18, 2026
Correction: Transition Care for Young People with Rare Bone and Mineral Conditions: A Scoping ReviewSílvia Coutinho, Lise Sofie Jensen, Thilini H Gamage, et al.
Calcified Tissue International|August 4, 2022
Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 StudyMaria Luisa Brandi, Suzanne Jan de Beur, Karine Briot, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2024
Systematic Review: Efficacy of Medical Therapy on Outcomes Important to Adult Patients With X-Linked HypophosphatemiaDalal S Ali, Reza D Mirza, Farah Alsarraf, et al.
RMD Open|September 22, 2021
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extensionKarine Briot, Anthony A Portale, Maria Luisa Brandi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 2025
Current Practices in Monitoring Children and Adults with X-linked Hypophosphatemia: A Global Survey of Expert ExperienceDalal S Ali, Farah Alsarraf, Hajar Abu Alrob, et al.
Journal of Bone and Mineral Metabolism|March 22, 2025
Methodology for the international working group clinical practice guidelines on X-linked hypophosphatemia in children and adultsDalal S Ali, Aliya A Khan, Reza D Mirza, et al.
Annals of the Rheumatic Diseases|December 20, 2023
Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget's disease of boneJonathan Phillips, Deepak Subedi, Steff C Lewis, et al.
ERJ Open Research|January 21, 2026
Clinical characteristics of diffuse idiopathic pulmonary neuroendocrine cell hyperplasiaMarissa O'Callaghan, Sarah H Forde, Alessandro N Franciosi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 17, 2020
Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study CohortOwen Cronin, Deepak Subedi, Laura Forsyth, et al.
Calcified Tissue International|November 8, 2025
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis ImperfectaJannie Dahl Hald, Christopher Weir, Catriona Keerie, et al.
Pageof 18